Search

Search Results

• REVIEW AND RECOMMENDATIONS ON MANAGEMENT OF ADULT FEMALE THALASSEMIA PATIE?TS WITH HYPOGONADISM BASED ON LITERATURE REVIEW AND EXPERIENCE OF ICET-A NETWORK SPECIALISTS

  Vincenzo De Sanctis

  e2017001

  2017-01-01

  https://doi.org/10.4084/mjhid.2017.001

  6163

  PDF: 1445

  HTML: 1940

• ACQUIRED HYPOGONADOTROPIC HYPOGONADISM (AHH) IN THALASSAEMIA MAJOR PATIENTS: AN UNDERDIAGNOSED CONDITION?

  Vincenzo De Sanctis

  e2016001

  2016-01-01

  https://doi.org/10.4084/mjhid.2016.001

  5210

  PDF: 1316

  HTML: 3591

• GROWTH AND ENDOCRINE FUNCTION IN TUNISIAN THALASSEMIA MAJOR PATIENTS

  Naouel GUIRAT

  e2018031

  2018-05-01

  https://doi.org/10.4084/mjhid.2018.031

  2892

  PDF: 1037

  HTML: 425

  TABLE: 196

  FIGURES: 261

• THALASSAEMIA AND ABERRATIONS OF GROWTH AND PUBERTY

  Andreas Kyriakou, Nicos Skordis

  e2009003

  2009-07-28

  1168

  PDF: 467

  HTML: 3222

• CLINICAL AND BIOCHEMICAL DATA OF ADULT THALASSEMIA MAJOR PATIENTS (TM) WITH MULTIPLE ENDOCRINE COMPLICATIONS (MEC) VERSUS TM PATIENTS WITH NORMAL ENDOCRINE FUNCTIONS: A RETROSPECTIVE LONG-TERM STUDY (40 YEARS) IN A TERTIARY CARE CENTER IN ITALY

  Vincenzo De Sanctis, Heba Elsedfy

  e2016022

  2016-04-12

  https://doi.org/10.4084/mjhid.2016.022

  3830

  PDF: 1040

  HTML: 3499

• Graves’ disease thyrotoxicosis and propylthiouracil related agranulocytosis successfully treated with therapeutic plasma exchange and g-csf followed by total thyroidectomy.

  Anna Candoni

  e2017058

  2017-10-16

  https://doi.org/10.4084/mjhid.2017.058

  2970

  PDF: 888

  HTML: 1425

  Fig.1: 169

  Fig.2: 181

• BISPHOSPHONATES IN LANGERHANS CELL HISTIOCYTOSIS: AN INTERNATIONAL RETROSPECTIVE CASE SERIES

  Deepak Chellapandian, Polyzois Makras, Gregory Kaltsas, Cor van den Bos, Lamia Naccache, Raajit Rampal, Anne-Sophie Carret, Sheila Weitzman, R. Maarten Egeler, Oussama Abla

  e2016033

  2016-07-01

  https://doi.org/10.4084/mjhid.2016.033

  3761

  PDF: 1263

  HTML: 1069

• INSULIN-LIKE GROWTH FACTOR-1 (IGF-1): DEMOGRAPHIC, CLINICAL AND LABORATORY DATA IN 120 CONSECUTIVE ADULT PATIENTS WITH THALASSAEMIA MAJOR

  V. De Sanctis

  e2014.074

  2014-11-01

  https://doi.org/10.4084/mjhid.2014.074

  2278

  PDF: 958

  HTML: 26950

• CONCISE REVIEW ON THE FREQUENCY, MAJOR RISK FACTORS AND SURVEILLANCE OF HEPATOCELLULAR CARCINOMA (HCC) IN ?-THALASSEMIAS: PAST, PRESENT AND FUTURE PERSPECTIVES Thalassaemia transfusion dependent, Hepatitis C, hepatocarcinoma.

  Vincenzo De Sanctis

  e2020006

  2020-01-01

  https://doi.org/10.4084/mjhid.2020.006

  4311

  PDF: 1536

  HTML: 460

• VITAMIN D STATUS IN THALASSEMIA MAJOR: AN UPDATE

  Ashraf Tawfik Soliman

  e2013057

  2013-09-02

  https://doi.org/10.4084/mjhid.2013.057

  2768

  PDF: 1098

  HTML: 2584

• GLUCOSE HOMEOSTASIS AND ΑSSESSMENT OF Β-CELL FUNCTION BY 3-HOUR ORAL GLUCOSE TOLERANCE (OGTT) IN PATIENTS WITH Β-THALASSEMIA MAJOR WITH SERUM FERRITIN BELOW 1,000 NG/DL: RESULTS FROM A SINGLE ICET-A CENTRE OGTT in thalassemia and iron overload

  Vincenzo De Sanctis, Ashraf Soliman, Shahina Daar, Ploutarchos Tzoulis , Salvatore Di Maio, Christos Kattamis

  e2023006

  2023-01-01

  https://doi.org/10.4084/MJHID.2023.006

  3977

  PDF: 1129

  HTML: 462

• The INFLUENCE OF NUTRITION ON DISEASE SEVERITY AND HEALTH-RELATED QUALITY OF LIFE IN ADULTS WITH SICKLE CELL DISEASE A Prospective Longitudinal Study

  Sanaa Kamal, Moheyeldeen Mohamed Naghib, Jamaan Al Zahrani, Huda Hassan, Karim Abdel Aziz Moawado, Omar Arrahman

  e2021007

  2021-01-01

  https://doi.org/10.4084/mjhid.2021.007

  2431

  PDF: 951

  HTML: 326

• DOES INSULIN LIKE GROWTH FACTOR-1 (IGF-1) DEFICIENCY HAVE A “PROTECTIVE” ROLE IN THE DEVELOPMENT OF DIABETIC RETINOPATHY IN THALASSEMIA MAJOR PATIENTS?

  Vincenzo De Sanctis

  e2015038

  2015-05-20

  https://doi.org/10.4084/mjhid.2015.038

  2000

  PDF: 943

  HTML: 5067

• THE FREQUENCY OF ADRENAL INSUFFICIENCY IN ADOLESCENTS AND YOUNG ADULTS WITH THALASSEMIA MAJOR VERSUS THALASSEMIA INTERMEDIA IN IRAN

  Sara Matin, Masoud Ghanei Jahromi, Zohreh Karemizadeh, Sezaneh Haghpanah, Vincenzo De Sanctis, Ashraf Soliman, Mehran Karimi

  e2015005

  2014-08-28

  https://doi.org/10.4084/mjhid.2015.005

  2055

  PDF: 1084

  HTML: 9553

• COULD PLASMA GLUCOSE (PG) INCREMENT (PG %) EXPAND THE CLINICAL WEIGHT OF OGTT? PRELIMINARY FINDINGS IN 19 TDT PATIENTS (Β-TDT) WITH NORMAL GLUCOSE TOLERANCE Plasma glucose (PG) increment (PG %) and pancretic β-cell dysfunction in thalassemia

  Vincenzo De Sanctis, Ashraf Soliman, Shahina Daar, Ploutarchos Tzoulis, Christos Kattamis

  e2025050

  2025-06-29

  https://doi.org/10.4084/MJHID.2025.050

  752

  PDF: 534

  HTML: 67

• EVALUATION OF GLUTATHIONE-S-TRANSFERASE P1 POLYMORPHISM AND ITS RELATION TO BONE MINERAL DENSITY IN EGYPTIAN CHILDREN AND ADOLESCENTS WITH BETA- THALASSEMIA MAJOR

  Seham Ragab

  e2016004

  2016-01-01

  https://doi.org/10.4084/mjhid.2016.004

  3942

  PDF: 866

  HTML: 2442

  Figures: 173

• GROUP-BASED TRAJECTORY MODELING OF PLATELET IN PATIENTS WITH APLASTIC ANEMIA: A STUDY BASED ON THE MIMIC DATABASE

  Lang Peng, Lixin Zou, Xiaoliu Liu

  e2025012

  2025-02-27

  https://doi.org/10.4084/MJHID.2025.012

  1031

  PDF: 1019

  Suppl. Files: 644

  HTML: 149

• ROLE OF STEM CELL FACTOR IN THE REACTIVATION OF HUMAN FETAL HEMOGLOBIN

  Marco Gabbianelli, Ugo Testa

  e2009009

  2009-11-12

  1168

  PDF: 483

  HTML: 4498